Narasin

This classification denotes an antibiotic with the molecular formula C43H72O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DZY9VU539P, chemically known as 2h-pyran-2-acetic acid, alpha-ethyl-6-(5-(2-(5-ethyltetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro(4.1.5.3)pentadec-13-en-9-yl)-2-hydroxy-1,3-dimethyl-4-oxoheptyl)tetrahydro-3,5-dimethyl- but more generally known as narasin, which bears US NIH Compound Identifier 65452. European Medicines Agency schedules Narasin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09163MIG. The term NARASIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 30, No. 10 1976, List 16). NARASIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O1C(CCC21OC1(OC(C(CC1C)C)C(C(=O)C(C(O)C(C1OC(C(CC1C)C)C(CC)C(=O)O)C)C)CC)C=CC2O)(C1OC(C(O)(CC1)CC)C)C.